BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 25, 2024
Breaking News: Try BioWorld for free for two weeks
See today's BioWorld Science
Home
» Novel anti-IL-17A inhibitor shows similar efficacy to biological therapies in IL-17-driven disorders
To read the full story,
subscribe
or
sign in
.
Immune
Novel anti-IL-17A inhibitor shows similar efficacy to biological therapies in IL-17-driven disorders
Sep. 1, 2023
No Comments
Interleukin-17A (IL-17A) is a pro-inflammatory cytokine involved in the pathogenesis of inflammatory, immune-mediated diseases such as psoriasis, psoriatic arthritis and others.
BioWorld Science
Conferences
Immune